title: [Role of new oral anticoagulants in interventional cardiology].
abstract: New oral anticoagulants constitute an important breakthrough for cardiologists and their patients. After reviewing their mechanism of action, their role in the context of interventional cardiology, particularly for patients with acute coronary syndromes, is discussed.
authors.affiliation: Cardiologie interventionnelle, polyclinique de Courlancy, 38, rue de Courlancy, 51100 Reims, France. camille.brasselet@orange.fr
authors.forename: C
authors.initials: C
authors.lastname: Brasselet
authors.forename: S
authors.initials: S
authors.lastname: Duval
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000601:surgery* / Q000628:therapy; D000284:Administration, Oral; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D001779:Blood Coagulation Factors / Q000187:drug effects; D006348:Cardiac Surgical Procedures / Q000379:methods; D002309:Cardiology; D000069604:Dabigatran; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D062645:Percutaneous Coronary Intervention / Q000379:methods; D011720:Pyrazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D011728:Pyridones / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D016896:Treatment Outcome; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D001779:Blood Coagulation Factors; D009025:Morpholines; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; D015091:beta-Alanine; C522181:apixaban; D000069552:Rivaroxaban; D000069604:Dabigatran